Study design (if review, criteria of inclusion for studies)
Randomised controlled trial. Parallel design.
Participants
40 participants, of which 36 completed. Ages: 6-17 years. CCPT: Mean (range) 9.8 years (6-14 years); PEP: 10.4 years (6-17 years).
Interventions
CCPT versus PEP.
Outcome measures
FVC, FEV1 and FEF25-75, radiographic score (not reported).
Main results
Group B (PEP) demonstrated improved pulmonary function in all parameters as measured by change in percent predicted value for age, gender, and height. The changes in pulmonary function over the study period were: FVC, +6.57; FEV1, +5.98; and FEF25-75, +3.32. This improvement was significantly different from that of group A (PD&P) whose pulmonary function declined in all parameters (FVC, -2.17; FEV1, -2.28; FEF25-75, -0.24). The differences between treatment groups were statistically significant for the changes in FVC (p = 0.02) and FEV(1) (p = 0.04).
Authors' conclusions
Our results indicate that for our patients with cystic fibrosis, pulmonary physiotherapy with the PEP technique was superior to conventional physiotherapy with the PD&P technique.